Search

everythinglearnresearchcommunity

for

Search:↓

RU58841 significantly increases hair growth rate and initiates more hair cycles, but doesn't affect hair thickness, suggesting it could be a new treatment for baldness.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Male sperm disorders significantly contribute to infertility.

Human placenta hydrolysates help treat various diseases and aid healing.

Men with high testosterone may have higher morning blood pressure, unlike those with high DHT.

Creating evidence-based guidelines for gender incongruence is difficult due to the personalized nature of transgender medicine.

Post-COVID-19 hair loss is different from androgenetic alopecia and can be identified by lower copper and higher selenium levels.

Combining zinc hyaluronate electroporation with photostimulating therapy is more effective for treating hair loss in men and women.

Combining RU58841 and minoxidil significantly increases hair growth.

Combining shikimic acid and Prunus mume extract may effectively treat acne naturally.

Smad1 and Smad5 are essential for hair follicle development and stem cell sleepiness.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

Sebaceous glands in the skin play a key role in absorbing the antiandrogen drug RU 58841, especially when it's encapsulated in liposomes.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

New treatments for hair loss are being developed using molecular biology.

Blocking CRF-R1 can reduce alcohol intake in stressed mice.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

The gel with special fat-loaded particles from rice bran could be an effective skin treatment for hair loss.

Avicennia marina extract and avicequinone C can potentially promote hair growth and treat hair loss by interfering with hair loss mechanisms and boosting growth factors.

Hair loss may increase heart disease risk.

Herbs can potentially treat hair loss by inhibiting a key enzyme and promoting hair growth, and deficiencies in zinc, biotin, and iron are linked to hair loss.

De nouvelles thérapies promettent de mieux traiter la perte de cheveux due à l'alopécie androgénétique.

Alopecia significantly harms emotional and social well-being.

All five human steroid 5α-reductase enzymes are found in the endoplasmic reticulum.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

The compounds tested could potentially treat hair loss and alopecia.